Hemoteq AG is a leading company in the field of contract development and manufacturing (CDMO) of specialty coatings for medical devices and components. The company focuses on drug coatings for combination products, offering a 360-degree approach from ideation to mass production. Hemoteq provides reliable customized solutions in coating design, product and process development, product approval, and mass production. Additionally, Hemoteq customers have access to the global expertise and resources of the Freudenberg Medical Group, making Hemoteq a hub for strategic innovations at the intersection of medical technology, pharmaceuticals, and biotechnology. The Hemoteq quality management system is certified according to ISO 13485:2016 and authorized for the Medical Device Single Audit Program (MDSAP). Founded in 1999, Hemoteq is located in Würselen near Aachen, Germany.
There is no investment information
No recent news or press coverage available for Hemoteq AG.